Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men.

Grinspoon S, Corcoran C, Stanley T, Baaj A, Basgoz N, Klibanski A.

J Clin Endocrinol Metab. 2000 Jan;85(1):60-5.

PMID:
10634364
2.

Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.

Grinspoon S, Corcoran C, Stanley T, Katznelson L, Klibanski A.

J Clin Endocrinol Metab. 1998 Dec;83(12):4251-6.

PMID:
9851759
3.

Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.

Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, Walsh M, Guccione A, Cannan J, Heller H, Basgoz N, Klibanski A.

J Clin Endocrinol Metab. 1996 Nov;81(11):4051-8.

PMID:
8923860
4.

Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.

Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, Grinspoon S.

J Clin Endocrinol Metab. 2000 Jan;85(1):35-41.

PMID:
10634360
5.

Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.

Miller K, Corcoran C, Armstrong C, Caramelli K, Anderson E, Cotton D, Basgoz N, Hirschhorn L, Tuomala R, Schoenfeld D, Daugherty C, Mazer N, Grinspoon S.

J Clin Endocrinol Metab. 1998 Aug;83(8):2717-25.

PMID:
9709937
6.

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A.

Ann Intern Med. 1998 Jul 1;129(1):18-26.

PMID:
9652995
7.

Testosterone replacement for hypogonadism: clinical findings and best practices.

Hengge UR.

AIDS Read. 2003 Dec;13(12 Suppl):S15-21. Review.

PMID:
14959695
8.

Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.

Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK.

J Clin Endocrinol Metab. 2001 May;86(5):2020-6.

PMID:
11344201
9.
10.

Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.

Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, Shen R, Arver S, Beall G.

J Clin Endocrinol Metab. 1998 Sep;83(9):3155-62.

PMID:
9745419
11.

Depression, Testosterone concentration, sexual dysfunction and methadone use among men with hypogonadism and HIV Infection.

Amini Lari M, Parsa N, Marzban M, Shams M, Faramarzi H.

AIDS Behav. 2012 Nov;16(8):2236-43. doi: 10.1007/s10461-012-0234-x.

PMID:
22722881
12.

Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.

Grinspoon S, Corcoran C, Miller K, Biller BM, Askari H, Wang E, Hubbard J, Anderson EJ, Basgoz N, Heller HM, Klibanski A.

J Clin Endocrinol Metab. 1997 May;82(5):1332-7. Erratum in: J Clin Endocrinol Metab 1997 Oct;82(10):3360.

PMID:
9141512
13.

Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial.

Grinspoon S, Corcoran C, Parlman K, Costello M, Rosenthal D, Anderson E, Stanley T, Schoenfeld D, Burrows B, Hayden D, Basgoz N, Klibanski A.

Ann Intern Med. 2000 Sep 5;133(5):348-55.

PMID:
10979879
14.

Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy.

Rietschel P, Corcoran C, Stanley T, Basgoz N, Klibanski A, Grinspoon S.

Clin Infect Dis. 2000 Nov;31(5):1240-4. Epub 2000 Nov 2.

PMID:
11073758
15.

Reduced bone density in androgen-deficient women with acquired immune deficiency syndrome wasting.

Huang JS, Wilkie SJ, Sullivan MP, Grinspoon S.

J Clin Endocrinol Metab. 2001 Aug;86(8):3533-9.

PMID:
11502775
16.

Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.

Giltay EJ, Tishova YA, Mskhalaya GJ, Gooren LJ, Saad F, Kalinchenko SY.

J Sex Med. 2010 Jul;7(7):2572-82. doi: 10.1111/j.1743-6109.2010.01859.x. Epub 2010 May 26.

PMID:
20524974
17.

Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.

Blick G, Khera M, Bhattacharya RK, Kushner H, Miner MM.

Postgrad Med. 2013 Mar;125(2):19-29. doi: 10.3810/pgm.2013.03.2638.

PMID:
23816768
18.
19.

A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms.

Rabkin JG, Wagner GJ, Rabkin R.

Arch Gen Psychiatry. 2000 Feb;57(2):141-7; discussion 155-6.

PMID:
10665616

Supplemental Content

Support Center